The aim of this project is to develop glycan specific probes in the form of fluorescent or DNA-modified molecularly imprinted polymer (MIP) nanoparticles for use in clinically relevant cancer diagnostics technologies. The synthetic probes will be used alone or in combination with antibodies in novel MIP-antibody proximity ligation assays for detection of soluble or cell surface biomarkers using state of the art imaging technologies. The proposal is a joint project of Malmö University, Umeå University, Uppsala University and two companies: ImaGene-iT and Phase Holographic Imaging AB.